Skip to main content

Table 6 Selected characteristics of subjects with recurrent parasitaemia in the SCD and non-SCD groups

From: A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine in Ghanaian paediatric sickle cell and non-sickle cell disease patients with acute uncomplicated malaria

Age (yrs) Genotype Admission parasitaemia Day of recurrence Treatment received PCR result Day 7 drug levels
9 SS 640 21 AA New infection DQ-21 ng/ml
4 SS/SD 2480 35 AA Recrudescence DQ-20 ng/ml
2.5 HbAA 79520 42 AL Recrudescence DL- ND
7 HbAA 63400 42 AL New infection DL - ND
  1. SS = sickle cell anaemia, HbAA = non-SCD, AA = artesunate-amodiaquine, AL = artemether-lumefantrine, DQ = desethylamodiaquine, DL = desbutyllumefantrine, ND = not done.